Nephrology Dialysis Transplantation has retracted a 2014 meeting abstract by a group of researchers on Crete whose ranks were inflated by one.
The abstract, titled “GENOTYPE (A) OF ENOS GENE AND R229Q MUTATION OF NPHS2 APPEARS TO BE ASSOCIATED WITH A WORSE OUTCOME IN PATIENTS WITH IGA NEPHROPATHY,” was presented at the European Renal Association-European Dialysis Association’s annual meeting.
Here’s what it reported: Continue reading Kidney journal pulls abstract for author issues
Molecules has pulled a 2010 article by a trio of chemists from Tunisia who tried — and succeeded, for a while, at least — to publish the same data twice. The article was titled “An Expeditious Synthesis of [1,2]Isoxazolidin-5-ones and [1,2]Oxazin-6-ones from Functional Allyl Bromide Derivatives.” And indeed it was expeditious. Here’s the notice: Continue reading A tale of two notices as Tunisian chemists lose two papers for duplicated data
Cardiovascular Research has retracted a 2010 paper by a group of prominent cardiology researchers in Brazil.
The reason: Image manipulation — which the authors say didn’t materially affect the conclusions of the paper.
The article, “FAK mediates the activation of cardiac fibroblasts induced by mechanical stress through regulation of the mTOR complex,” came from a group led by Ana Paula Dalla Costa, from the State University of Campinas.
Here’s the abstract of the study, which has been cited 19 times, according to Thomson Scientific’s Web of Knowledge: Continue reading Heart journal pulls paper for image manipulation
Update, 4 p.m. EST, 10/29/14: As a commenter points out, we didn’t quite get this one right. The Boldt paper that has been retracted was not previously retracted for lack of IRB approval. Rather, it was a heretofore unretracted article, from 1996, which German investigators have determined contained faked data. We’ve made edits below using strikethroughs, and have changed the headline to better reflect the content. We apologize for the errors.
We’ve commented before on the fact that we’ve noticed there’s often more to retractions whose stated reason is lack of institutional review board (IRB) approval. We can understand editors’ inclination to act as quickly as possible to issue a retraction, the scientific publishing equivalent of jailing Al Capone for tax evasion. But we appreciate it even more when said editors return to the scene of the crime, as it were, when new important details come out.
Case in point: Anesthesia & Analgesia has amended its retraction of a 2009 1996 study by Joachim Boldt — who with nearly 90 retractions once held the record in that department — based on findings that the data in that paper were fabricated.
The article was titled “Cardiopulmonary bypass priming using a high dose of a balanced hydroxyethyl starch versus an albumin-based priming strategy,” “The effects of albumin versus hydroxyethyl starch solution on cardiorespiratory and circulatory variables in critically ill patient.” had previously been retracted because Boldt had failed to obtain adequate ethics approval for the research. But now comes this, According to the retraction notice from editor in chief Steven Shafer: Continue reading Boldt’s data were fake in 1996 paper
The Journal of the American Academy of Dermatology has issued an expression of concern about a 2012 article reporting the experience of military burn unit treating a rare ailment called toxic epidermal necrolysis.
According to the notice, which is behind a paywall (for shame!), the paper appears to have overstated the number of cases the hospital itself has treated of the life-threatening condition: Continue reading Journal expresses concerns over “possible data irregularities” in paper from Army medical center docs
Phyllis Wise, the chancellor of the University of Illinois and an obstetrics researcher, has called for a massive correction of a 2006 paper in Neuroscience for work she appears to have tried to pass off as having been previously unpublished — but which wasn’t.
The article, “Estrogen therapy: Does it help or hurt the adult and aging brain? Insights derived from animal models,” has been cited 47 times, according to Thomson Scientific’s Web of Knowledge.
And it had caught also the attention of readers on PubPeer, who noted that: Continue reading U. Illinois chancellor earns mega-correction for duplicate publication
Diederik Stapel, the Dutch social psychologist and admitted data fabricator — and owner of 54 retraction notices — is now teaching at a college in the town of Tilburg.
According to Omroep Brabant, Stapel was offered the job as a kind of adjunct at Fontys Academy for Creative Industries to teach social philosophy. The site quotes a Nick Welman explaining the rationale for hiring Stapel (per Google Translate): Continue reading Curtain up on second act for Dutch fraudster Stapel: College teacher
The authors of a 1997 paper on macular degeneration have lost the article after readers noticed uncanny similarities with a 1996 publication from several of the same authors.
The retracted article, “Radiation therapy for macular degeneration: Technical considerations and preliminary results,” appeared in the International Journal of Radiation Oncology*Biology*Physics — otherwise known as the “Red Journal.” The first author, Luther W. Brady, is a leading U.S. oncologist.
According to the retraction notice: Continue reading Double dipping on trial data topples 17-year-old macular degeneration article
An architecture professor at the University of Arizona has been sanctioned — lightly — for plagiarizing from the thesis of one of her masters’ students.
According to a report in the Arizona Daily Star, the professor, Susannah Dickinson: Continue reading Arizona prof plagiarizes student’s thesis, gets reprimanded, but keeps her job
A pair of researchers who have been calling for the retraction of two papers by cardiology researcher Don Poldermans say the New England Journal of Medicine is “not justified” “disappointing” in its refusal to pull the articles.
A little background: Poldermans resigned from Erasmus University in 2011 after having been accused of misconduct. Last week, we reported that the European Heart Journal had issued an expression of concern for a 2001 article on which he was first author.
The New England Journal of Medicine added editor’s notes to two of Poldermans’ articles. But as Larry Husten at Forbes reports, the journal has no intention of retracting the papers: Continue reading Critics of Poldermans’ work baffled by NEJM stance on DECREASE papers